Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Incyte Corp Transaction History

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main

$94.9 Billion
Q3 2024

A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Incyte Corp stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 81,511 shares of INCY stock, worth $5.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

81,511

Previous 246,585 66.94%

Holding current value

$5.9 Million

Previous $14.9 Million 63.96%

% of portfolio

0.01%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$57.33 - $68.61 $9.46 Million - $11.3 Million	-165,074 Reduced 66.94%	81,511 $5.39 Million
Q2 2024 Aug 14, 2024	BUY	$51.18 - $63.75 $4.46 Million - $5.55 Million	87,087 Added 54.6%	246,585 $14.9 Million
Q1 2024 May 15, 2024	BUY	$56.55 - $66.59 $1.81 Million - $2.13 Million	32,006 Added 25.1%	159,498 $9.09 Million
Q4 2023 Feb 14, 2024	SELL	$52.16 - $64.19 $6.62 Million - $8.15 Million	-127,010 Reduced 49.91%	127,492 $8.01 Million
Q3 2023 Nov 14, 2023	SELL	$57.77 - $65.93 $13.9 Million - $15.9 Million	-240,492 Reduced 48.58%	254,502 $14.7 Million
Q2 2023 May 17, 2024	BUY	$60.95 - $75.51 $20.4 Million - $25.3 Million	335,496 Added 210.34%	494,994 $30.8 Million
Q2 2023 Aug 14, 2023	BUY	$60.95 - $75.51 $1.75 Million - $2.17 Million	28,677 Added 6.15%	494,994 $30.8 Million
Q1 2023 May 17, 2024	BUY	$70.23 - $86.01 $1.16 Million - $1.42 Million	16,529 Added 3.67%	466,317 $33.7 Million
Q1 2023 May 15, 2023	BUY	$70.23 - $86.01 $1.16 Million - $1.42 Million	16,529 Added 3.67%	466,317 $33.7 Million
Q4 2022 May 17, 2024	BUY	$67.18 - $84.11 $19.5 Million - $24.4 Million	290,290 Added 182.0%	449,788 $36.1 Million
Q4 2022 Feb 14, 2023	BUY	$67.18 - $84.11 $6.48 Million - $8.11 Million	96,474 Added 27.31%	449,788 $36.1 Million
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $353,533 - $442,638	-5,342 Reduced 1.49%	353,314 $23.5 Million
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $2.75 Million - $3.45 Million	-41,530 Reduced 10.38%	358,656 $27.2 Million
Q1 2022 May 16, 2022	BUY	$66.02 - $79.71 $17.1 Million - $20.6 Million	258,851 Added 183.15%	400,186 $0
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $6.73 Million - $7.87 Million	106,202 Added 302.29%	141,335 $10.5 Million
Q2 2021 Aug 16, 2021	BUY	$79.87 - $87.53 $2.76 Million - $3.03 Million	34,597 Added 6454.66%	35,133 $2.96 Million
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $285,683 - $377,679	-3,758 Reduced 87.52%	536 $43,000
Q4 2020 Feb 16, 2021	SELL	$80.74 - $97.7 $384,241 - $464,954	-4,759 Reduced 52.57%	4,294 $373,000
Q3 2020 Nov 16, 2020	SELL	$85.07 - $109.69 $299,871 - $386,657	-3,525 Reduced 28.03%	9,053 $812,000
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $3.17 Million - $4.65 Million	-42,715 Reduced 77.25%	12,578 $1.31 Million
Q1 2020 May 15, 2020	BUY	$63.18 - $85.97 $2.85 Million - $3.88 Million	45,176 Added 446.54%	55,293 $4.05 Million
Q4 2019 Feb 14, 2020	SELL	$73.04 - $95.72 $737,850 - $966,963	-10,102 Reduced 49.96%	10,117 $885,000
Q3 2019 Nov 14, 2019	SELL	$72.82 - $86.52 $196,613 - $233,604	-2,700 Reduced 11.78%	20,219 $1.5 Million
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $1.5 Million - $1.81 Million	20,419 Added 816.76%	22,919 $1.95 Million
Q2 2018 Aug 14, 2018	SELL	$60.85 - $83.98 $2.13 Million - $2.94 Million	-34,950 Reduced 93.32%	2,500 $168,000
Q1 2018 May 15, 2018	BUY	$83.06 - $100.98 $2.9 Million - $3.53 Million	34,950 Added 1398.0%	37,450 $3.12 Million
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $265,710 - $331,144	-2,840 Reduced 53.18%	2,500 $237,000
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $582,861 - $738,361	5,340	5,340 $624,000

Others Institutions Holding INCY

# of Institutions

651

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.

Account

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Incyte Corp Transaction History